Press Releases - 2022-12-06

Date	Title	Company
06-Dec-2022	Global Wound Care Market Outlook Report 2022: A $34 Billion Market in 2031 from $22 Billion in 2021 - ResearchAndMarkets.com	Businesswire
06-Dec-2022	Medidata Launches New myMedidata Native App to Expedite Study Start Up and Improve Patient Experience	Medidata
06-Dec-2022	Heads of RCN, RCP and new Patient Safety Commissioner will highlight need to improve both staff and patient safety at the first Safety for All Conference tomorrow	Safer Healthcare & Biosafety Network
06-Dec-2022	Insights on the Nucleic Acid Isolation & Purification Global Market to 2027 - Molecular Diagnostics and Personalized Medicine Presents Opportunities - ResearchAndMarkets.com	Businesswire
06-Dec-2022	Entact Bio Launches with $81 Million Series A to Develop Precision Medicines for Targeted Protein Enhancement	Businesswire
06-Dec-2022	Equillium and Ono Pharmaceutical Announce Exclusive Option and Asset Purchase Agreement for the Development and Commercialization of Itolizumab	Businesswire
06-Dec-2022	Vega Therapeutics launches and unveils its first-in-class antibody therapy for von Willebrand disease at ASH Annual Meeting	Businesswire
06-Dec-2022	98% of Pharmaceutical Executives Agree on Importance of Omnichannel as Half of Companies Are Not Optimizing Physician Engagement across Touchpoints, Study Finds	Businesswire
06-Dec-2022	Regulations slowing down digital transformation for most drug development companies	AspenTech
06-Dec-2022	Coriolis Pharma Appoints Formulation and Drug Development Expert Bruce Kerwin to Scientific Advisory Board	Coriolis Pharma
06-Dec-2022	Documentary explores tuberculosis amongst Canterbury’s homeless	University of Kent
06-Dec-2022	Virtual Hospital Ward Solution Secures £1 million Investment to Support the NHS	Midven
06-Dec-2022	Tiziana Life Sciences Announces Date of Annual General Meeting 2022	Tiziana Life Sciences
06-Dec-2022	Pfizer and Clear Creek Bio to Collaborate on a Research Program Targeting SARS-CoV-2 Papain-Like Protease	Businesswire
06-Dec-2022	SQZ Biotechnologies Receives FDA Fast Track Designation for its eAPC Therapeutic Candidate for Treatment of HPV16+ Tumors and Presents Clinical Data for Multiple Programs at the European Society for Medical Oncology Immuno-Oncology Congress	Businesswire
06-Dec-2022	Platelet Services celebrates record year	Platelet Services
06-Dec-2022	Immutep announces GMP manufacturing process developed for IMP761, a first-in-class LAG-3 agonist for autoimmune disease	Immutep
06-Dec-2022	F-star Therapeutics Presents Clinical Data on FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, at ESMO-IO 2022 Congress	F-star Therapeutics
06-Dec-2022	Achilles Therapeutics Presents Encouraging Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma at ESMO IO Congress 2022	Achilles Therapeutics
06-Dec-2022	Blood Group Typing Market to achieve CAGR of 9.3% from 2023 to 2032, owing to growing requirement for safe blood transfusions \| insightSLICE	insightSLICE